广州医科大学学报
廣州醫科大學學報
엄주의과대학학보
Academic Journal of Guangzhou Medical College
2014年
5期
77-79
,共3页
小儿%消化功能紊乱%法莫替丁%多潘立酮
小兒%消化功能紊亂%法莫替丁%多潘立酮
소인%소화공능문란%법막체정%다반립동
Children%Digestive disorders%Famotidine%Domperidone
目的::探究多潘立酮联合法莫替丁治疗小儿消化功能紊乱的临床疗效。方法:选择我院于2013年5月-2014年8月接收的150例小儿消化紊乱患者作为研究对象,将其随机分为实验组和对照组,每组平均75例,对照组患儿接受多潘立酮单药治疗,实验组患者接受潘立酮联合莫替丁治疗,分析两组患者的临床疗效。结果:经过相应的对症治疗,两组患儿的恶心呕吐、上腹不适等症状得以改善。实验组腹泻、便秘、腹痛患儿的临床治疗总有效率均明显高于对照组患儿( P<0.05),实验组患儿的临床治疗起效时间为(9.5±2.2) d,明显短于对照组患儿(13.1±3.2) d(P<0.05)。结论:多潘立酮联合法莫替丁对小儿消化功能紊乱的临床疗效显著,无明显不良反应且药效快。
目的::探究多潘立酮聯閤法莫替丁治療小兒消化功能紊亂的臨床療效。方法:選擇我院于2013年5月-2014年8月接收的150例小兒消化紊亂患者作為研究對象,將其隨機分為實驗組和對照組,每組平均75例,對照組患兒接受多潘立酮單藥治療,實驗組患者接受潘立酮聯閤莫替丁治療,分析兩組患者的臨床療效。結果:經過相應的對癥治療,兩組患兒的噁心嘔吐、上腹不適等癥狀得以改善。實驗組腹瀉、便祕、腹痛患兒的臨床治療總有效率均明顯高于對照組患兒( P<0.05),實驗組患兒的臨床治療起效時間為(9.5±2.2) d,明顯短于對照組患兒(13.1±3.2) d(P<0.05)。結論:多潘立酮聯閤法莫替丁對小兒消化功能紊亂的臨床療效顯著,無明顯不良反應且藥效快。
목적::탐구다반립동연합법막체정치료소인소화공능문란적림상료효。방법:선택아원우2013년5월-2014년8월접수적150례소인소화문란환자작위연구대상,장기수궤분위실험조화대조조,매조평균75례,대조조환인접수다반립동단약치료,실험조환자접수반립동연합막체정치료,분석량조환자적림상료효。결과:경과상응적대증치료,량조환인적악심구토、상복불괄등증상득이개선。실험조복사、편비、복통환인적림상치료총유효솔균명현고우대조조환인( P<0.05),실험조환인적림상치료기효시간위(9.5±2.2) d,명현단우대조조환인(13.1±3.2) d(P<0.05)。결론:다반립동연합법막체정대소인소화공능문란적림상료효현저,무명현불량반응차약효쾌。
Objective:To explore the clinical therapeutic effect of domperidone combined with famotidine in the treatment of pediatric digestive disorders. Methods: in our hospital in 2013 May -2014 year in August received 150 cases of pediatric digestive disorder patients as the research object, it will be randomly divided into experimental group and control group, each group average of 75 cases, the control group were received domperidone monotherapy, patients in the experimental group received domperidone combined famotidine treatment, clinical analysis two groups of patients.Results:after corresponding treatment, two groups of children with nausea and vomiting, epigastric discomfort and other symptoms improved. The experimental group of diarrhea, constipation, abdominal pain in children with a total effective rate of clinical treatment were significantly higher than that of the control group patients, the difference between the two groups was significant and statistically significant (P<0.05) in the experimental group, the clinical treatment of the onset time for (9.5+2.2) d, significantly shorter than the control group patients (13.1+3.2) d (P<0.05).Conclusion:domperidone combined with famotidine in clinical effect of pediatric digestive disorders significantly, no significant adverse reactions and fast effect.